| Eunice Seung-hee Cho, MD | |
|
17700 Se 272nd St, Covington, WA 98042-4951 | |
| (253) 372-7102 | |
| (253) 372-7225 |
| Full Name | Eunice Seung-hee Cho |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 24 Years |
| Location | 17700 Se 272nd St, Covington, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083703276 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 00048136 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tacoma General Allenmore Hospital | Tacoma, WA | Hospital |
| Multicare Covington Medical Center | Covington, WA | Hospital |
| Multicare Auburn Medical Center | Auburn, WA | Hospital |
| Multicare Good Samaritan Hospital | Puyallup, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Multicare Health System | 7719899897 | 1704 |
News Archive
An analysis of genomic changes in ovarian cancer has provided the most comprehensive and integrated view of cancer genes for any cancer type to date. Ovarian serous adenocarcinoma tumors from 500 patients were examined by The Cancer Genome Atlas (TCGA) Research Network and analyses are reported in the June 30, 2011, issue of Nature.
RepliCel Life Sciences Inc., a clinical stage regenerative medicine company focused on the development of autologous cell therapies, today announced the submission of a Clinical Trial Application (CTA) to the German Competent Authority, the Paul-Ehrlich-Institut (PEI), requesting clearance to initiate a Phase 1 clinical trial investigating the use of RCS-01 to treat patients suffering from aged and UV-damaged skin.
Physicists at McMaster University have for the first time identified a simple mechanism used by potentially deadly bacteria to fend off antibiotics, a discovery which is providing new insights into how germs adapt and behave at a level of detail never seen before.
Countries which have an average working week that exceeds 48 hours die an average of two years earlier than those that work for 45 hours or less, new research shows.
› Verified 5 days ago
| Entity Name | Multicare Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497766638 PECOS PAC ID: 7719899897 Enrollment ID: O20031105000760 |
News Archive
An analysis of genomic changes in ovarian cancer has provided the most comprehensive and integrated view of cancer genes for any cancer type to date. Ovarian serous adenocarcinoma tumors from 500 patients were examined by The Cancer Genome Atlas (TCGA) Research Network and analyses are reported in the June 30, 2011, issue of Nature.
RepliCel Life Sciences Inc., a clinical stage regenerative medicine company focused on the development of autologous cell therapies, today announced the submission of a Clinical Trial Application (CTA) to the German Competent Authority, the Paul-Ehrlich-Institut (PEI), requesting clearance to initiate a Phase 1 clinical trial investigating the use of RCS-01 to treat patients suffering from aged and UV-damaged skin.
Physicists at McMaster University have for the first time identified a simple mechanism used by potentially deadly bacteria to fend off antibiotics, a discovery which is providing new insights into how germs adapt and behave at a level of detail never seen before.
Countries which have an average working week that exceeds 48 hours die an average of two years earlier than those that work for 45 hours or less, new research shows.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eunice Seung-hee Cho, MD 17700 Se 272nd St, Covington, WA 98042-4951 Ph: (253) 372-7102 | Eunice Seung-hee Cho, MD 17700 Se 272nd St, Covington, WA 98042-4951 Ph: (253) 372-7102 |
News Archive
An analysis of genomic changes in ovarian cancer has provided the most comprehensive and integrated view of cancer genes for any cancer type to date. Ovarian serous adenocarcinoma tumors from 500 patients were examined by The Cancer Genome Atlas (TCGA) Research Network and analyses are reported in the June 30, 2011, issue of Nature.
RepliCel Life Sciences Inc., a clinical stage regenerative medicine company focused on the development of autologous cell therapies, today announced the submission of a Clinical Trial Application (CTA) to the German Competent Authority, the Paul-Ehrlich-Institut (PEI), requesting clearance to initiate a Phase 1 clinical trial investigating the use of RCS-01 to treat patients suffering from aged and UV-damaged skin.
Physicists at McMaster University have for the first time identified a simple mechanism used by potentially deadly bacteria to fend off antibiotics, a discovery which is providing new insights into how germs adapt and behave at a level of detail never seen before.
Countries which have an average working week that exceeds 48 hours die an average of two years earlier than those that work for 45 hours or less, new research shows.
› Verified 5 days ago
Alejandro Arnold, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 17700 Se 272nd St, Covington, WA 98042 Phone: 253-372-7102 Fax: 253-372-1225 |